Literature DB >> 19155260

Eli Lilly pays record $1.4bn for promoting off-label use of olanzapine.

Zosia Kmietowicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19155260     DOI： 10.1136/bmj.b217

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Off-label use of atypical antipsychotics: cause for concern?

Authors:  Andrew McKean; Erik Monasterio
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

2.  Ten common questions (and their answers) about off-label drug use.

Authors:  Christopher M Wittich; Christopher M Burkle; William L Lanier
Journal:  Mayo Clin Proc       Date:  2012-08-06       Impact factor: 7.616

3.  Off-label drug use in Psychiatry Outpatient Department: A prospective study at a Tertiary Care Teaching Hospital.

Authors:  Darshan Kharadi; Kamlesh Patel; Devang Rana; Varsha Patel
Journal:  J Basic Clin Pharm       Date:  2015-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.